NOVAVAX INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Novavax Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Novavax Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$134M, a 6.68% decline year-over-year.
  • Novavax Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$301M, a 51.9% increase year-over-year.
  • Novavax Inc annual Operating Income (Loss) for 2023 was -$567M, a 12.1% increase from 2022.
  • Novavax Inc annual Operating Income (Loss) for 2022 was -$645M, a 61.8% increase from 2021.
  • Novavax Inc annual Operating Income (Loss) for 2021 was -$1.69B, a 305% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$301M -$134M -$8.39M -6.68% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$293M $161M +$106M +190% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$399M -$145M +$168M +53.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$567M -$184M +$60.3M +24.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$627M -$126M +$1.56M +1.22% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$628M $55.5M +$538M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$1.17B -$313M -$522M -249% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$645M -$244M +$581M +70.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$1.23B -$127M +$180M +58.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1.41B -$483M -$137M -39.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$1.27B $209M +$418M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$1.69B -$825M -$642M -351% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$1.04B -$307M -$113M -58.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$931M -$346M -$329M -1931% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$602M -$209M -$186M -811% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$417M -$183M -$154M -537% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$263M -$194M -$179M -1194% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$83.6M -$17M +$19.6M +53.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$103M -$22.9M +$17.3M +43.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$121M -$28.7M +$17.8M +38.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$138M -$15M +$26.9M +64.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$165M -$36.7M +$5.33M +12.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$171M -$40.2M +$3.29M +7.56% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$174M -$46.5M +$1.27M +2.66% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$175M -$41.9M -$272K -0.65% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$175M -$42M -$522K -1.26% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$174M -$43.5M -$2.69M -6.58% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$172M -$47.8M +$6.26M +11.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-11
Q3 2017 -$178M -$41.6M +$21.7M +34.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$200M -$41.5M +$35M +45.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$235M -$40.8M +$34.4M +45.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$269M -$54M +$24.9M +31.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$294M -$63.3M -$30.1M -90.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$264M -$76.5M -$55.7M -267% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$208M -$75.3M -$50.9M -210% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$157M -$78.9M -$47.2M -149% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 -$110M -$33.2M -$13.4M -67.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$96.6M -$20.8M -$2.97M -16.6% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$93.6M -$24.3M -$9.93M -69% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$83.7M -$31.7M -$17.4M -122% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 -$66.3M -$19.8M -$4.51M -29.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$61.8M -$17.9M -$4.95M -38.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$56.8M -$14.4M -$4.38M -43.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$52.4M -$14.3M -$4.76M -50.1% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$47.7M -$15.3M -$8.43M -123% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$39.2M -$12.9M -$7.04M -120% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$32.2M -$10M -$2.54M -34% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$29.7M -$9.49M -$5.23M -123% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 -$24.4M -$6.85M -$2.88M -72.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$21.6M -$5.86M +$66K +1.12% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$21.6M -$7.47M -$37K -0.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$21.6M -$4.26M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 -$3.97M +$6.57M +62.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$5.92M +$3.55M +37.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$7.43M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$10.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$9.47M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.